NFKB1 and cancer: Interestingly, the NF-κB signalling pathway is activated in numerous cancers, leading to decreased apoptosis in malignant cells [92,93], and one may hypothesize from our study that the pro-apoptotic effect of the fg-TiO2 could be partly due to the inhibition of the NF-κB signalling pathway.